SECTOR : Biotech
ENTRY DATE : 2013
EXIT DATE : 2019
BUSINESS : Venture Capital
WEB : www.linkedin.com/opsona-therapeutics

Opsona Therapeutics

Novel therapeutic approaches to key targets of the innate immune system

Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of major human diseases, including autoimmune and inflammatory diseases, transplant rejection, cancer, diabetes, Alzheimer’s disease and atherosclerosis. The company was founded in 2004 by three world-renowned immunologists at Trinity College in Dublin.

PRESS RELEASE(S) :

02/10/2013• Opsona Therapeutics Limited raises an additional €3 million from Omnes Capital in Series C extension
Lire